HIV - AIDS (main): Difference between revisions

No edit summary
(Text replacement - "* " to "*")
(25 intermediate revisions by 9 users not shown)
Line 1: Line 1:
==Background==
==Background==
* In HIV+ patient presenting to ED, absolute lymphocyte count (ALC) can be used as surrogate for CD4 count <ref> Napoli AM, Fischer CM, Pines JM, Soe-lin H, Goyal M, Milzman D. Absolute
*In HIV+ patient presenting to ED, absolute lymphocyte count (ALC) can be used as surrogate for CD4 count <ref> Napoli AM, Fischer CM, Pines JM, Soe-lin H, Goyal M, Milzman D. Absolute
lymphocyte count in the emergency department predicts a low CD4 count in admitted HIV-positive patients. Acad Emerg Med. 2011 Apr;18(4):385-9. doi:10.1111/j.1553-2712.2011.01031.x. Erratum in: Acad Emerg Med. 2011 May;18(5):565.</ref>
lymphocyte count in the emergency department predicts a low CD4 count in admitted HIV-positive patients. Acad Emerg Med. 2011 Apr;18(4):385-9. doi:10.1111/j.1553-2712.2011.01031.x. Erratum in: Acad Emerg Med. 2011 May;18(5):565.</ref>
* A CD4 count of <200 is very likely if the ED ALC is <950 and less likely if the ALC is >1700
**A CD4 count of <200 is very likely if the ED ALC is <950 and less likely if the ALC is >1700
* ALC is useful to confirm, but not exclude a low CD4
**ALC is useful to confirm, but not exclude a low CD4
* 14% of people with HIV in US aren't aware of being HIV+
*Approximately 1.2 million people in the US are living with HIV <ref name="HIV">CDC. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data. HIV Surveillance Report. 2015; 20(2):1-70.</ref>
**13% of people with HIV in US aren't aware <ref name="HIV"></ref>
**Most affected: homosexual & bisexual men, particularly African American <ref name="HIV"></ref>


{{HIV CD4 Chart}}
{{HIV CD4 Chart}}
Line 10: Line 12:
==Clinical Features==
==Clinical Features==
===Acute Infection===
===Acute Infection===
*Misdiagnosed frequently as "mono" or "flu"
*Misdiagnosed frequently as "mononucleosis" or "flu"
*Largest viral load, widespread dissemination of virus, and most infectious stage<ref>Serrano KD, Westergaard RP. Diagnosis and management of acute HIV in the emergency department. EM Reports, 2012:33;16.</ref>
*Largest viral load, widespread dissemination of virus, and most infectious stage<ref>Serrano KD, Westergaard RP. Diagnosis and management of acute HIV in the emergency department. EM Reports, 2012:33;16.</ref>
*Symptoms develop 2-4wks after exposure; last for <14d
*Symptoms develop 2-4wks after exposure; last for <14d
Line 16: Line 18:
**Fatigue (70-90%)
**Fatigue (70-90%)
**[[Pharyngitis]] (>70%)
**[[Pharyngitis]] (>70%)
**Rash (40-80%)
**Rash (40-80%) - [[Pruritic papular eruption of HIV]]
**Headache (30-70%)
**[[Headache]] (30-70%)
**[[Lymphadenopathy]] (40-70%)
**[[Lymphadenopathy]] (40-70%)


Line 26: Line 28:
===Asymptomatic===
===Asymptomatic===
*Lasts for ~8yr
*Lasts for ~8yr
*Pts may have conditions that are more common in pts w/ HIV but no indicator conditions
*Patients may have conditions that are more common in patients with HIV but no indicator conditions
**Thrush
**[[Thrush]]
**Persistent vulvovaginal candidiasis
**Persistent [[Candidiasis|candidia vaginitis]]
**Peripheral neuropathy
**Peripheral neuropathy
**Cervical dysplasia
**Cervical dysplasia
**Recurrent [[Herpes Zoster]]
**Recurrent [[Herpes Zoster]]
**ITP
**[[ITP]]


===AIDS===
===AIDS===
Line 40: Line 42:
**Disseminated [[TB]]
**Disseminated [[TB]]
**Invasive cervical cancer
**Invasive cervical cancer
**Esophageal candidiasis
**[[Esophageal candidiasis]]
**[[Cryptococcosis]]
**[[Cryptococcosis]]
**[[Cryptosporidiosis]]
**[[Cryptosporidiosis]]
**[[CMV  Retinitis]]
**[[CMV  Retinitis]]
**HSV
**[[HSV]]
**[[Kaposi sarcoma]]
**[[Kaposi sarcoma]]
**Brain lymphoma
**[[Pruritic papular eruption of HIV]]
**[[Primary CNS lymphoma|Lymphoma]]
**MAC
**MAC
**PCP PNA
**[[PCP pneumonia]]
**PML
**[[Progressive multifocal leukoencephalopathy]]
**Brain [[Toxoplasmosis]]
**Brain [[Toxoplasmosis]]
**HIV [[Encephalitis]]
**HIV [[Encephalitis]]
**HIV wasting syndrome
**HIV wasting syndrome
**Disseminated histoplasmosis
**Disseminated [[histoplasmosis]]
**Isosporiasis
**Isosporiasis
**Recurrent [[Salmonella]] septicemia  
**Recurrent [[Salmonella]] septicemia  
Line 61: Line 64:
{{HIV associated conditions}}
{{HIV associated conditions}}


*Consider medication side effects: lactic acidosis, neuropyschiatric effects, hepatic toxicity, renal toxicity, Steven-Johnson's, cytopenias, GI symptoms, endocrine abnormalities. <ref> Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.</ref>
==Evaluation==
 
==Diagnosis==
*Typical lab testing for HIV:
*Typical lab testing for HIV:
**Screening test: ELISA
**Screening test: ELISA
**Confirmatory test: Western blot
**Confirmatory test: Western blot
*Lactic acidosis may be seen as a side effect of many anti-retroviral medications.
*Maintain low threshold for additional testing in setting of suspicion of opportunistic infections
*Maintain low threshold for additional testing in setting of suspicion of opportunistic infections (OI)
*CDC (2006) recommends routine HIV screening in health care settings using an opt-out approach <ref>Branson B, Handsfield H, Lampe M. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. MMWR. 2006; 55: 1-17.</ref>
**Opt-out screening: performing the test after notifying the patient it will be performed & giving them the option to decline


==Management==
==Management==
Line 92: Line 94:
*Cachexia or weakness
*Cachexia or weakness
*Unable to care for self/receive care
*Unable to care for self/receive care
*Unable to assure F/U
*Unable to assure follow up


===Suggested Discharge===
===Suggested Discharge===
Line 99: Line 101:
*Able to tolerate PO
*Able to tolerate PO
*Adequate follow-up
*Adequate follow-up
*Able to comply with D/C instructions
*Able to comply with discharge instructions


==See Also==
==See Also==

Revision as of 08:15, 11 July 2017

Background

  • In HIV+ patient presenting to ED, absolute lymphocyte count (ALC) can be used as surrogate for CD4 count [1]
    • A CD4 count of <200 is very likely if the ED ALC is <950 and less likely if the ALC is >1700
    • ALC is useful to confirm, but not exclude a low CD4
  • Approximately 1.2 million people in the US are living with HIV [2]
    • 13% of people with HIV in US aren't aware [2]
    • Most affected: homosexual & bisexual men, particularly African American [2]

HIV Associated Diseases by CD4 Level

CD4 Count Stage Diseases
>500 Early disease Similar to non-immunocompromised patients (Consider HAART medication side-effects)
200-500 Intermediate disease Kaposi's sarcoma, Candida, bacterial respiratory infections
<200 Late disease PCP, central line infection, MAC, TB, CMV, drug fever, sinusitis, endocarditis, lymphoma, histoplasmosis, cryptococcus, PML
<100 Very late disease Cryptococcus, Cryptosporidium, Toxoplasmosis
<50 Final Stage CMV retinitis, MAC

Clinical Features

Acute Infection

Seroconversion

  • HIV Ab detectable 3-8wk after infection
  • If negative Ab test but high suspicion, can HIV viral load.

Asymptomatic

  • Lasts for ~8yr
  • Patients may have conditions that are more common in patients with HIV but no indicator conditions

AIDS

Differential Diagnosis

HIV associated conditions

Evaluation

  • Typical lab testing for HIV:
    • Screening test: ELISA
    • Confirmatory test: Western blot
  • Maintain low threshold for additional testing in setting of suspicion of opportunistic infections
  • CDC (2006) recommends routine HIV screening in health care settings using an opt-out approach [5]
    • Opt-out screening: performing the test after notifying the patient it will be performed & giving them the option to decline

Management

HAART

Highly Active Anti-Retroviral Therapy

  • Reduces progression to AIDS and transmission risk
  • CDC Guidelines = all HIV+ individuals should be started on HAART, regardless of CD4 count or viral load[6]
  • Typical first line regimens include a reverse transcriptase inhibitor (NRTI) and an integrase inhibitor
    • tenofovir/emtricitabine (Truvada) PLUS raltegravir (Isentress)
    • tenofovir/emtricitabine (Truvada) PLUS dolutegravir (Tivicay)

Disposition

Suggested Admission

  • New presentation of fever of unknown origin
  • Hypoxemia worse than baseline or PaO2 <60
  • Suspected PCP
  • Suspected TB
  • New CNS symptoms
  • Intractable diarrhea
  • Suicidal
  • Suspected CMV retinitis
  • Ophthalmicus zoster
  • Cachexia or weakness
  • Unable to care for self/receive care
  • Unable to assure follow up

Suggested Discharge

  • Normal or baseline vitals
  • Stable medical condition
  • Able to tolerate PO
  • Adequate follow-up
  • Able to comply with discharge instructions

See Also

References

  1. Napoli AM, Fischer CM, Pines JM, Soe-lin H, Goyal M, Milzman D. Absolute lymphocyte count in the emergency department predicts a low CD4 count in admitted HIV-positive patients. Acad Emerg Med. 2011 Apr;18(4):385-9. doi:10.1111/j.1553-2712.2011.01031.x. Erratum in: Acad Emerg Med. 2011 May;18(5):565.
  2. 2.0 2.1 2.2 CDC. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data. HIV Surveillance Report. 2015; 20(2):1-70.
  3. Serrano KD, Westergaard RP. Diagnosis and management of acute HIV in the emergency department. EM Reports, 2012:33;16.
  4. Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.
  5. Branson B, Handsfield H, Lampe M. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. MMWR. 2006; 55: 1-17.
  6. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. https://aidsinfo.nih.gov/guidelines Accessed 03/04/16